Skip to content

Medical-device intelligence

LBT: Electrophoresis, Cholesterol Via Esterase-Oxidase, Hdl

FDA product code LBT: Electrophoresis, Cholesterol Via Esterase-Oxidase, Hdl. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LBT
FDA device name
Electrophoresis, Cholesterol Via Esterase-Oxidase, Hdl
Device class
1
Regulation number
862.1475
Medical specialty
Clinical Chemistry
Review panel
CH

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

8 clearance records and 0 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Jun 15, 1979 to Aug 4, 2000.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LBT · Electrophoresis, Cholesterol Via Esterase-Oxidase, Hdl80

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

8 matching records
Device / recordCompany in FDA recordSourceSource date
HDL CHOLESTEROL PLUSK000568 · LBTRoche Diagnostics Corp.510(k)Aug 4, 2000FDA decision date
HYDRAGEL LDL/HDL CHOL DIRECT KIT-P.N. 4005, HYDRAGEL 7 LDL/HDL CHOL DIRECT KIT-P.N. 4103, HYDRAGEL LDL/HDL CHOL DIRECT 0K990250 · LBTMorax510(k)Jun 18, 1999FDA decision date
HYDRAGEL 7,15,30, CHOL-HDL KITK972015 · LBTMorax510(k)Oct 27, 1997FDA decision date
REP ULTRA HDL,VLDL/LDL CHOLESTEROL SYSTEMK904035 · LBTHelena Laboratories510(k)Nov 9, 1990FDA decision date
REP HDL-8 KIT, NO. 3188, REP HDL-16 KIT, NO. 3187K894366 · LBTHelena Laboratories510(k)Aug 31, 1989FDA decision date
REP HDL ELECTROPHORESIS METHODK882368 · LBTHelena Laboratories510(k)Aug 8, 1988FDA decision date
TITAN GEL HDL CHOLESTEROL KITK873547 · LBTHelena Laboratories510(k)Oct 2, 1987FDA decision date
ELECTROPHORESIS REAGENT SET, HDLK790791 · LBTGelman Sciences, Inc.510(k)Jun 15, 1979FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗